Elpis Biopharmaceuticals to Present New Data on Multi-Mechanism Armored CAR-T Therapy at PEGS Summit 2025 ...Middle East

Proprietary cytokine-engineered CAR-T therapy shows durable anti-tumor activity and low-dose efficacy in solid tumors LEXINGTON, Mass. and SINGAPORE, May 12, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies...

Hence then, the article about elpis biopharmaceuticals to present new data on multi mechanism armored car t therapy at pegs summit 2025 was published today ( Monday 12/05/2025 - 04:33 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Elpis Biopharmaceuticals to Present New Data on Multi-Mechanism Armored CAR-T Therapy at PEGS Summit 2025 )

Also on site :

• China’s LNG Imports Rebound Late in the Year After a Prolonged Slump
• China’s EV Exports Soar by 87%
• NYSE Content Advisory: Pre-Market Update + S&P 500 To End 2025 Trade This Week, Up 18% So Far This Year